01 / SIGNAL
GHRH-receptor activity
Literature reports binding at pituitary GHRH receptors, a primary input to endogenous GH-release signalling.
GHRH Analog · Research Compound
Tesa
Tesamorelin.
A stabilized GHRH-analog research peptide. Literature examines its activity at the pituitary GHRH receptor and downstream effects on endogenous growth-hormone release. Reference information only — not for human or animal consumption.
- Class
- GHRH Analog
- Pathway
- Pituitary GH Release
- Route
- Subcutaneous
// 01About the compound
Tesamorelin is a stabilized GHRH (growth hormone-releasing hormone) analog research peptide. Published literature describes its activity at pituitary GHRH receptors and downstream effects on endogenous GH and IGF-1 signalling.
Published trial data has examined Tesamorelin's effects on visceral adipose tissue endpoints in clinical-research populations.
It is included in the Max Nutrition USA catalog as a current focus of GHRH-pathway research literature.
// 02Mechanism — what the literature describes
Four signalling steps reported in the published research on GHRH-analog peptides.
02 / RELEASE
Pulsatile-release pathway
Research examines preservation of pulsatile endogenous GH-release patterns versus exogenous GH administration.
03 / TARGET
Visceral-adipose endpoints
Trial data examines effects on visceral adipose-tissue endpoints in clinical-research populations.
04 / OUTCOMES
Body-composition research
Published literature examines longitudinal body-composition and IGF-1 endpoints.
// 03Research focus areas
Visceral-adipose research
Trial data examines visceral adipose-tissue endpoints.
Anthropometric endpoints
Studies measure waist-circumference and body-composition endpoints over multi-week observation windows.
IGF-1 axis research
GHRH-receptor activity is examined for downstream IGF-1 signalling endpoints.
Endogenous pathway
Pulsatile endogenous GH-release research differentiates GHRH analogs from exogenous HGH literature.
Sleep-architecture research
GH-pulse pharmacology is examined for associations with slow-wave sleep dynamics.
Longevity-pathway research
GHRH-axis literature examines tissue-maintenance and longevity-related endpoints.
// 04Related research compounds
Endogenous GH research
CJC-1295 + Ipamorelin
Combined GHRH/GHRP research peptide; growth-hormone-pulse signalling literature.
View page → Triple-agonist researchRetatrutide
Triple-agonist incretin research compound in current metabolic literature.
View page → Tissue-repair researchBPC-157 + TB-500
Connective-tissue and systemic-repair pathway research compound.
View page → Mitochondrial researchMOTS-C 40mg
Mitochondrial-derived peptide research; cellular-energy pathway literature.
View page →Research inquiries.
Direct line.
DM @max_nutritionusa for current Tesamorelin stock, pricing, CoA requests, and shipping. By contacting us you affirm you are a qualified researcher and will use any compound purchased strictly for laboratory research — not for human or animal consumption. We do not provide dosing or medical advice.
Disclaimer — Research Use Only
All products offered by Max Nutrition USA are sold strictly for in vitro laboratory research purposes only. Not for human or animal consumption. Not for diagnostic, therapeutic, or veterinary use.
These compounds have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease. They are not approved drugs, dietary supplements, or cosmetics under the Federal Food, Drug, and Cosmetic Act.
All content on this site — including product names, mechanism descriptions, and references to scientific literature — is provided for educational and informational purposes only. Nothing on this site constitutes medical, pharmaceutical, or dosing advice. Always consult a qualified, licensed healthcare professional before considering any application involving these or any other compounds.
Buyer attestation. By submitting an inquiry or placing an order, you represent and warrant that you are a qualified professional or researcher of legal age in your jurisdiction; that you will use these products solely for in vitro laboratory research; that you will not administer, ingest, inject, or otherwise consume any product purchased; and that you will handle, store, and dispose of all materials in accordance with all applicable federal, state, and local laws and regulations.
Max Nutrition USA does not provide dosing, administration, protocol, or medical advice through any channel, including direct messages, email, or phone. Any informal use-related questions will be declined.
Max Nutrition USA assumes no liability for misuse, improper handling, or use outside of a controlled research setting. The purchaser assumes all risks and responsibilities associated with the use, storage, and handling of these products.